Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy?

Tivey, Ann; Ullah, Mohammed; Beech, Alison; Ng, Cassandra; Cove-Smith, Laura

Tivey, Ann; Ullah, Mohammed; Beech, Alison; Ng, Cassandra; Cove-Smith, Laura.

Afiliação

Tivey A; The Christie NHS Foundation Trust, United Kingdom; Manchester University NHS Foundation Trust, United Kingdom. Electronic address: ann.tivey@nhs.net.
Ullah M; Manchester University NHS Foundation Trust, United Kingdom.
Beech A; Manchester University NHS Foundation Trust, United Kingdom.
Ng C; Manchester University NHS Foundation Trust, United Kingdom.
Cove-Smith L; The Christie NHS Foundation Trust, United Kingdom; Manchester University NHS Foundation Trust, United Kingdom.

J Geriatr Oncol ; 11(7): 1154-1156, 2020 09.

Article em En | MEDLINE | ID: mdl-32171694

Assuntos

Fragilidade; Neoplasias Torácicas; Idoso; Idoso Fragilizado; Fragilidade/induzido quimicamente; Fragilidade/diagnóstico; Avaliação Geriátrica; Humanos; Programas de Rastreamento; Neoplasias Torácicas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Torácicas / Fragilidade Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Humans Idioma: En Revista: J Geriatr Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google